A Multinational, Multicenter, Retrospective, Observational Drug Utilisation Study of Seroquel Extended Release (XR) Prescribed by Psychiatrists as Treatment for Major Depressive Disorder (MDD) in Selected Countries in the European Union (EU)

Trial Profile

A Multinational, Multicenter, Retrospective, Observational Drug Utilisation Study of Seroquel Extended Release (XR) Prescribed by Psychiatrists as Treatment for Major Depressive Disorder (MDD) in Selected Countries in the European Union (EU)

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Oct 2014

At a glance

  • Drugs Quetiapine (Primary)
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Acronyms EUDUS
  • Sponsors AstraZeneca
  • Most Recent Events

    • 24 Oct 2014 Last checked against ClinicalTrials.gov record.
    • 20 Oct 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 15 May 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top